Databean

Executive Summary

Databean is a full-service clinical research organization (CRO) headquartered in San Francisco, specializing in supporting medtech and biotech startups. The company integrates scientific, regulatory, and clinical expertise with proprietary IT solutions to accelerate the development of novel therapies and devices for chronic health conditions. Its end-to-end services encompass trial design, data management, regulatory strategy, and post-market surveillance, positioning it as a strategic partner for early-stage companies navigating complex clinical pathways. Founded in 2015, Databean addresses the growing need for specialized CROs that can offer both deep domain knowledge and technological agility. As the medtech and biotech sectors continue to expand, particularly in digital health and AI-enabled diagnostics, Databean is well-positioned to capture market share among startups seeking lean, efficient clinical development support. The company's focus on chronic conditions aligns with major healthcare trends, and its San Francisco base provides access to a vibrant innovation ecosystem. While competition from larger CROs exists, Databean's niche focus and integrated IT capabilities serve as differentiators, though the company's private status and limited public visibility make it harder to assess its market traction definitively.

Upcoming Catalysts (preview)

• TBDStrategic partnership with a digital health accelerator40% success
• TBDKey client milestone (e.g., FDA clearance or pivotal trial start) for a partnered device30% success